leisure time -WSS

leisure time

author：Wikipedia 2025-09-29 22:53:16 - browse：25691

Vertex Pharmaceuticals - sunset — Bill Sikes/AP

LONDON — Regulators in the U.K. on Thursday approved a CRISPR-based medicine to treat both sickle cell disease and beta thalassemia, making it the world’s first therapy built on the revolutionary gene-editing technology and ushering in a new era of genetic medicine.

The authorization of the therapy, from Vertex Pharmaceuticals and CRISPR Therapeutics, is itself not a surprise. Clinical trials have shown the one-time treatment enabled many sickle cell patients to live free of debilitating pain crises and relieved thalassemia patients of needing regular blood transfusions, raising hopes that they have been effectively cured. But it also stands as a major achievement, coming just over a decade after the first and seminal lab experiments that showed CRISPR’s potential as a gene-editing tool were published.

In granting conditional approval to the therapy, which will have the brand name Casgevy and is also known as exa-cel, the U.K.’s Medicines and Healthcare products Regulatory Agency jumped ahead of its counterparts in the U.S. and Europe, which are also reviewing the medicine, in greenlighting the globe’s first CRISPR treatment. The MHRA’s authorization is for patients who are at least 12 years old.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medical leaders decry Supreme Court decision on affirmative action
Next article： A new initiative will help leaders fight the next pandemic

explore

WSS

Election results set back Medicaid expansion plans

Sage considers ways to reduce costs following FDA rejection

Tuberculosis patients need more than just free medication

ASCO Daily Recap: CAR

Severe weather updates: 1 million customers without power in 11 states as storms pummel East Coast

Google's generative AI to analyze medical images — and talk to docs

focus

leisure time

entertainment

United colonoscopy coverage change 'may cost lives,' doctors say

Sweden knocks USA out of World Cup in penalty kicks

Guidelines to prevent youth baseball injuries need more muscle

Sweden knocks USA out of World Cup in penalty kicks

Apple is now the first public company to be valued at $3 trillion

With heat waves through August, officials warn of health risks

FDA approval of Sarepta Duchenne genetic therapy gives me hope

How CRISPR works, explained in two minutes

As demand for Covid shots wanes, Moderna seeks its next success

Novartis is flashing warning signs about its newly acquired myelofibrosis drug

explore

Mexico finds 491 migrants being held at vacant lot, almost all are from Guatemala

CMS got Medicare Advantage quality rating wrong, judge rules

Illumina board agrees to spin off Grail, as divestment plans proceed

Tuberculosis patients need more than just free medication

Paxlovid rebound happens. Why and to whom are still a mystery

Elevance PBM president out as customers face prescription chaos

leisure time

focus

explore

focus